This contract involves the delivery of the pharmaceutical product INN Sebelipase alfa, in the form of a 2 mg/ml concentrate for solution for infusion, packaged in 10 ml vials. The procurement is conducted under Regulation 10/2011 and is awarded to the University Specialized Hospital for Active Treat
Contract awarded. Originally published 5 months ago.
Only 1 prior award here — too little to read.
In healthcare medical, UNIVERSITY SPECIALIZED HOSPITAL FOR ACTIVE TREATMENT IN ENDOCRINOLOGY "ACAD. IV. PENCHEV" EAD has awarded 1 contract to 1 supplier.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the supply, installation, commissioning, training of personnel, and warranty service for a high-end ultrasound system needed by the University Specialized Hospital for Active Treatment in Endocrinology "Acad. Ivan Penchev". The equipment must meet the specifications outlined i
This procurement opportunity involves the supply of pharmaceutical products for the University Specialized Hospital for Active Treatment in Endocrinology "Acad. Ivan Penchev" EAD. The contract includes 111 distinct items, and participants can submit offers for one, several, or all of these items. Ea
This contract involves the supply of pharmaceutical products for the needs of the University Specialized Hospital for Active Treatment in Endocrinology "Acad. Ivan Penchev" EAD. The procurement includes 173 distinct items, and participants can submit offers for one, several, or all of the items. Eac
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Royal Hospital Donnybrook seeks suppliers to provide and install handrails in 5 patient corridors.
Deliver community-based health improvement programmes promoting physical activity, healthy eating, and behaviour change for adults in Western and Southern Northern Ireland health areas.
BHSCT seeks market engagement from suppliers of cochlear implants and accessories through a questionnaire submission by 1st September 2026.
